Leaderboard
Anzeige
medline.ch
En
|
De
Impressum
No articles selected!
View Cart
You are here:
Oncology
»
Urologic Neoplasms
15. April 2026
Search
medline.ch
Urologic Neoplasms
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
Musculoskeletal System
Blood
Endocrine System
Gynecologic Neoplasms
Skin
Gastrointestinal
ORL
Respiratory Tract
Urologic Neoplasms
CNS
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Rect Top
Anzeige
Zoom:
Page 1 of 8875
Articles 1 - 20 / 177496
Soluble immune checkpoints as diagnostic biomarkers in bladder cancer.
Biomark Res
Andrzejczak A, Krajewski W, Jasku, Chorbi, Tomkiewicz A, Sarat K, Mroczek R, Ma, Szyde, Karabon L.
PMID: 41981705 [PubMed - in process]
MTHFD1L in muscle invasive bladder cancer: a multi-cohort study on prognosis and therapeutic response.
World J Surg Oncol
Peng S, Liu Y, Huang P, Liu Q, Zhang L, Hsu CY, Zeng Y, Lu J, Zhao H, Cai C.
PMID: 41981612 [PubMed - as supplied by publisher]
Comment on "A prognostic microRNA-based signature for localized clear cell renal cell carcinoma: the Bio-miR study".
Br J Cancer
Liang J, Ren S, Wu G.
PMID: 41981141 [PubMed - as supplied by publisher]
Delayed-onset central adrenal insufficiency following adjuvant pembrolizumab therapy for renal cell carcinoma.
BMJ Case Rep
Eisa N.
PMID: 41980799 [PubMed - indexed for MEDLINE]
Performance of an Artificial Intelligence Foundation Model for Prostate Radiotherapy Segmentation.
JCO Clin Cancer Inform
Doucette M, Liao CY, Lin MH, Jiang S, Nguyen D, Yang DX.
PMID: 41980236 [PubMed - indexed for MEDLINE]
Multiclass Classification of Renal Tumor Subtypes: Addressing Diagnostic Challenges Using a Texture-Informed Deep Hybrid CNN-Transformer.
J Imaging Inform Med
Azam MT, Balaha HM, Aboudessouki A, Ali KM, Ali A, El-Melegy MT, Idrees MT, Ghazal M, Khalil A, Gondim DD, El-Baz A.
PMID: 41979758 [PubMed - as supplied by publisher]
Diagnostic Aspects of a Bacillus Calmette-Guërin (BCG) Infection Following Intravesical Treatment for Bladder Cancer.
Clin Lab
Cha JH, Kim KJ, Yun SG, Nam MH, Lee GI, Cho Y.
PMID: 41979622 [PubMed - indexed for MEDLINE]
Clinical management of oligoprogressive renal cell carcinoma.
Expert Rev Anticancer Ther
Bernstein E, Schoenhals J, Dason S, Wang SJ, Singer EA, Runcie K.
PMID: 41979231 [PubMed - as supplied by publisher]
Guideline of guidelines: lutetium-177 PSMA radioligand therapy in advanced prostate cancer.
BJU Int
Al-Khanaty A, Chen D, Walbaum J, Hennes D, Delgado C, Dinneen E, Eapen R, Hofman MS, Azad AA, Murphy DG, Lawrentschuk N, Perera M.
PMID: 41979224 [PubMed - as supplied by publisher]
Saruparib in combination with androgen receptor pathway inhibitors in metastatic hormone-sensitive prostate cancer: EvoPAR-Prostate01.
Future Oncol
Azad AA, Agarwal N, Armstrong AJ, Hellmis E, Sugimoto M, Ürün Y, Xing N, Aregay M, Lima J, Meulendijks D, Chi KN.
PMID: 41979035 [PubMed - as supplied by publisher]
Incidence of High-Risk Prostate Cancer in Korea: Insights From Real-World Data Between 2010 and 2020.
J Korean Med Sci
Ko YH, Kim SW, Son NH.
PMID: 41978922 [PubMed - indexed for MEDLINE]
Diagnosis and Management of Synchronous Prostate and Rectal Cancer in a Patient.
Cureus
Iqbal H, Haldar N, Mueller AC.
PMID: 41978589 [PubMed]
Embryonal Rhabdomyosarcoma of the Prostate in a Young Adult.
Acta Med Indones
Tagaylo XJ, So JS, See Iv MC.
PMID: 41978295 [PubMed - indexed for MEDLINE]
A Prolonged Nightly Fasting Plus Telehealth Coaching Intervention (PNF+) for Men on Androgen Deprivation Therapy for PCa: A Pilot Feasibility Randomized Controlled Trial.
Nutrients
Wen KY, Freedman J, Zarrabi KK, Slamon R, Smith R, Liang J, Mille P, Tester WJ, Kelly W.
PMID: 41978216 [PubMed - indexed for MEDLINE]
Matrix Metalloproteinases and Pro-Inflammatory Cytokines in Bladder Cancer: Diagnostic and Prognostic Perspectives: Narrative Review.
Int J Mol Sci
Lipka U, Orywal K, Gudowska-Sawczuk M.
PMID: 41977399 [PubMed - indexed for MEDLINE]
Immune Escape in Renal Cell Carcinoma: Latest Research and Treatment Strategies.
Int J Mol Sci
Huang K, Chen K.
PMID: 41977251 [PubMed - indexed for MEDLINE]
LC-MS/MS Method for Therapeutic Drug Monitoring of Abiraterone, Darolutamide, Apalutamide, Enzalutamide, and Metabolites in Prostate Cancer Patients.
Int J Mol Sci
Posocco B, Pasin D, De Cesaro N, Pivetta A, Gagno S, Canil G, Cecchin E, Cecchin R, Speziani S, Dri A, Bortolus G, Spina M, Santarossa S, Puglisi F, Fratino L, Cecchin E.
PMID: 41977206 [PubMed - indexed for MEDLINE]
Underestimation of Prostate Cancer Grade in Transperineal Fusion Biopsy and Its Predictive Factors: Correlation of Biopsy Findings with Post-Da Vinci Radical Prostatectomy Specimens.
J Clin Med
Krzepkowski HA, Z, Wal, Kami, D, Syry.
PMID: 41977080 [PubMed]
Diagnostic Accuracy of [(68)Ga]Ga-PSMA-11 PET-CT in Characterising Bone Lesions in Prostate Cancer: A Single-Centre Study.
Cancers (Basel)
Sachdeva A, Salem M, Jenkins J, Wong K, Cook GJR, Azad G.
PMID: 41976313 [PubMed]
Open Surgical Management of Renal Cell Carcinoma with Infradiaphragmatic Venous Tumor Thrombus (Mayo Levels 0-III): The Epitome of Surgical Self-Reliance in Urology.
Cancers (Basel)
Novacescu D, Baloi A, Latcu S, Zara F, Sandesc D, Dumitru CS, Condoiu C, Bardan R, Dema V, Caprariu R, Cut TG, Cumpanas A.
PMID: 41976303 [PubMed]
Articles 1 - 20 / 177496
Page 1 of 8875
Rect Bottom
Anzeige
Adserver Footer
Time frame
--unlimited--
1 Week
1 Month
3 Months
6 Months
1 Year
2 Years
3 Years
5 Years
10 Years
Sky right 1
Anzeige
Mediscope AG E-mail:
info@mediscope.ch
Disclaimer
|
Privacy Policy